Farther Finance Advisors’s LENZ Therapeutics LENZ Stock Holding History

Farther Finance Advisors’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.38K	Buy	595 +258	+77%	+$2.08K	﹤0.01%	4979
2026 Q1	$3.15K	Sell	337 -159	-32%	-$2.23K	﹤0.01%	4715
2025 Q4	$7.94K	Buy	496 +356	+254%	+$10.4K	﹤0.01%	4062
2025 Q3	$6.52K	Buy	+140	New	+$5.15K	﹤0.01%	3647

Other funds holding LENZ

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

AFC

Ares Financial Consulting Calabasas, California $139M AUM

Farther Finance Advisors's LENZ Position: Q2 2026 in Review

Farther Finance Advisors increased its LENZ Therapeutics (LENZ) stake by 77% in Q2 2026, buying an estimated $2.08K and bringing the position to 595 shares worth $3.38K. The position accounts for ﹤0.01% of the portfolio, ranked #4979.

Farther Finance Advisors first reported a position in LENZ in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.94K in Q4 2025. 6 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

Farther Finance Advisors held 595 shares of LENZ Therapeutics worth $3.38K as of Q2 2026.
Farther Finance Advisors bought 258 LENZ Therapeutics shares in Q2 2026, an estimated $2.08K.
LENZ Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4979 holding.
Farther Finance Advisors first reported a position in LENZ Therapeutics in Q3 2025 and has held it in 4 quarters since.
Farther Finance Advisors's LENZ Therapeutics position peaked at $7.94K in Q4 2025.
6 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.